Colorcon

Memo to Applied DNA: It’s payday in Pennsylvania

By GREGORY ZELLER // Memorandums of understanding are swell and all, but for a scrappy enterprise forever waging a bottom-line battle, nothing beats getting paid. So, Stony Brook-based Applied DNA Sciences should be very happy to receive the first of two “milestone payments” accompanying the March 31 signing of a new licensing deal with Pennsylvania manufacturer Colorcon Inc. Announced Thursday, the license and cooperation agreement grants Colorcon the exclusive worldwide right to add Applied DNA’s…


Missiles, cars, leather … finally, biotech pushes pills

By GREGORY ZELLER // A biotech with a penchant for leather, foreign automobiles, high-tech weaponry and next-gen digital imaging is finally getting around to pharmaceuticals. Actually, that’s not true – Stony Brook-based Applied DNA Sciences has already this year announced multiple pharma-nutra-focused forays, including the production of DNA chains for in-vitro diagnostic and DNA-based therapeutic research purposes. But in announcing a technology license memorandum of understanding with Pennsylvania-based “hard dose” specialist Colorcon Inc., Applied DNA…